Val-Cit-PAB-MMAE | CAS#644981-35-1 | MMAE ADC | MedKoo
MC-Val-Cit-PAB-MMAF | CAS 863971-17-9 | AbMole BioScience | MC-Val-Cit-PAB-MMAF Price
SuO-Val-Cit-PAB-MMAE
DBCO-(PEG2-VC-PAB-MMAE)2 | CAS#:2259318-55-1 | Chemsrc
Mal-PEG8-Val-Cit-PAB-MMAE TM-T18299 | CymitQuimica
Azido-PEG3-Val-Cit-PAB-PNP | CAS#:2055047-18-0 | Chemsrc
Enzyme-linked immunosorbent assays for quantification of MMAE-conjugated ADCs and total antibodies in cynomolgus monkey sera - ScienceDirect
Fmoc-Val-Cit-PAB-MMAE, 1350456-56-2 | BroadPharm
endo-BCN-PEG4-Val-Cit-PAB-MMAE | ADC Linkers | MedChemExpress
Val-Cit-PAB-MMAE| CAS:644981-35-1|Chemexpress
Val-Cit-PAB-MMAE | ≥99%(HPLC) | drug-linker conjugate for ADC | AdooQ®
IJMS | Free Full-Text | Bivalent EGFR-Targeting DARPin-MMAE Conjugates | HTML
Anti-HER2 ADC preparation and potency evaluation against HER2 overexpression human cancer cell lines
AEC45656 | 1350456-56-2 | Fmoc-Val-Cit-PAB-MMAE
FV171750 | 644981-35-1 | Val-Cit-PAB-MMAE | Biosynth Carbosynth
Val-Cit-PAB-MMAE | Drug-Linker Conjugate For ADC | MedChemExpress
Construction of paclitaxel-based antibody–drug conjugates with a PEGylated linker to achieve superior therapeutic index | Signal Transduction and Targeted Therapy
Acid-PEG4-Val-Cit-PAB-MMAE | BroadPharm
Val-Cit | Xi'an Confluore Biological Technology Co., Ltd.
Val-Cit-PAB-MMAE | Excenen PharmaTech
SC-VC-PAB-MMAE | Drug-Linker Conjugates for ADC | MedChemExpress
646502-53-6 | MC-Val-Cit-PAB-MMAE
FV171750 | 644981-35-1 | Val-Cit-PAB-MMAE | Biosynth Carbosynth
Amino-PEG4-Val-Cit-PAB-MMAE | AxisPharm
![KR20180075133A - [GRO Aptamer]-Drug Conjugates And Use Thereof - Google Patents](https://patentimages.storage.googleapis.com/8c/5b/c0/66bf2b565ad1ab/pat00018.png "KR20180075133A - [GRO Aptamer]-Drug Conjugates And Use Thereof - Google Patents")